Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19

Andrea M Lerner, Daphne A Robinson, Linda Yang, Carolyn F Williams, Lori M Newman, Joseph J Breen, Robert W Eisinger, Johanna S Schneider, Adaora A Adimora, Emily J Erbelding, Andrea M Lerner, Daphne A Robinson, Linda Yang, Carolyn F Williams, Lori M Newman, Joseph J Breen, Robert W Eisinger, Johanna S Schneider, Adaora A Adimora, Emily J Erbelding

Abstract

Over the past year, the SARS-CoV-2 pandemic has swept the globe, resulting in an enormous worldwide burden of infection and mortality. However, the additional toll resulting from long-term consequences of the pandemic has yet to be tallied. Heterogeneous disease manifestations and syndromes are now recognized among some persons after their initial recovery from SARS-CoV-2 infection, representing in the broadest sense a failure to return to a baseline state of health after acute SARS-CoV-2 infection. On 3 to 4 December 2020, the National Institute of Allergy and Infectious Diseases, in collaboration with other Institutes and Centers of the National Institutes of Health, convened a virtual workshop to summarize existing knowledge on postacute COVID-19 and to identify key knowledge gaps regarding this condition.

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M21-1043.

References

    1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2021. Accessed at on 1 March 2021.
    1. Carfì A , Bernabei R , Landi F ; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603-605. [PMID: ] doi:10.1001/jama.2020.12603
    1. Huang C , Huang L , Wang Y , et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220-232. [PMID: ] doi:10.1016/S0140-6736(20)32656-8
    1. Halpin S , O'Connor R , Sivan M . Long COVID and chronic COVID syndromes [Letter]. J Med Virol. 2021;93:1242-1243. [PMID: ] doi:10.1002/jmv.26587
    1. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. Preprint posted online 27 December 2020. doi:10.1101/2020.12.24.20248802
    1. Puntmann V , Nagel E . Cardiac involvement after recovering from COVID-19—reply. JAMA Cardiol. 2021;6:244-245. [PMID: ] doi:10.1001/jamacardio.2020.5285
    1. Rajpal S , Tong MS , Borchers J , et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection [Letter]. JAMA Cardiol. 2021;6:116-118. [PMID: ] doi:10.1001/jamacardio.2020.4916
    1. Feldstein LR , Rose EB , Randolph AG . Multisystem inflammatory syndrome in children in the United States. Reply [Letter]. N Engl J Med. 2020;383:1794-1795. [PMID: ] doi:10.1056/NEJMc2026136
    1. Jiang L , Tang K , Levin M , et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20:e276-e288. [PMID: ] doi:10.1016/S1473-3099(20)30651-4
    1. Bailey LC , Razzaghi H , Burrows EK , et al. Assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States. JAMA Pediatr. 2021;175:176-184. [PMID: ] doi:10.1001/jamapediatrics.2020.5052
    1. Carvalho-Schneider C , Laurent E , Lemaignen A , et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258-263. [PMID: ] doi:10.1016/j.cmi.2020.09.052
    1. Sudre CH , Murray B , Varsavsky T , et al. Attributes and predictors of long COVID. Nat Med. 2021. [PMID: ] doi:10.1038/s41591-021-01292-y
    1. Tenforde MW , Kim SS , Lindsell CJ , et al; IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993-998. [PMID: ] doi:10.15585/mmwr.mm6930e1
    1. Brown SM , Bose S , Banner-Goodspeed V , et al; Addressing Post Intensive Care Syndrome 01 (APICS-01) study team. Approaches to addressing post-intensive care syndrome among intensive care unit survivors. A narrative review. Ann Am Thorac Soc. 2019;16:947-956. [PMID: ] doi:10.1513/AnnalsATS.201812-913FR
    1. Datta SD , Talwar A , Lee JT . A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324:2251-2252. [PMID: ] doi:10.1001/jama.2020.22717
    1. Shah W , Hillman T , Playford ED , et al. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. [PMID: ] doi:10.1136/bmj.n136
    1. Salamanna F , Maglio M , Landini MP , et al. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne). 2020;7:594495. [PMID: ] doi:10.3389/fmed.2020.594495
    1. Gaebler C , Wang Z , Lorenzi JCC , et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021. [PMID: ] doi:10.1038/s41586-021-03207-w
    1. Woodruff MC , Ramonell RP , Nguyen DC , et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21:1506-1516. [PMID: ] doi:10.1038/s41590-020-00814-z
    1. Zuo Y , Estes SK , Ali RA , et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12. [PMID: ] doi:10.1126/scitranslmed.abd3876
    1. Bastard P , Rosen LB , Zhang Q , et al; HGID Lab. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370. [PMID: ] doi:10.1126/science.abd4585
    1. Rydyznski Moderbacher C, Ramirez SI, Dan JM, et al.. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183:996-1012.e19. [PMID: ] doi:10.1016/j.cell.2020.09.038
    1. Vella LA, Giles JR, Baxter AE, et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. medRxiv. Preprint posted online 6 October 2020. doi:10.1101/2020.09.25.20201863
    1. Pons S , Fodil S , Azoulay E , et al. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24:353. [PMID: ] doi:10.1186/s13054-020-03062-7
    1. Gupta A , Madhavan MV , Sehgal K , et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: ] doi:10.1038/s41591-020-0968-3
    1. Lee MH , Perl DP , Nair G , et al. Microvascular injury in the brains of patients with covid-19 [Letter]. N Engl J Med. 2021;384:481-483. [PMID: ] doi:10.1056/NEJMc2033369
    1. Leist SR , Dinnon KH 3rd , Schäfer A , et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell. 2020;183:1070-1085.e12. [PMID: ] doi:10.1016/j.cell.2020.09.050
    1. Zheng J , Wong LR , Li K , et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589:603-607. [PMID: ] doi:10.1038/s41586-020-2943-z
    1. Fischer T, Rutkai I, Mayer M, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Research Square. Preprint posted online 24 August 2020. doi:10.21203/-59871/v1
    1. Johansen MD , Irving A , Montagutelli X , et al. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol. 2020;13:877-891. [PMID: ] doi:10.1038/s41385-020-00340-z
    1. Salahudeen AA , Choi SS , Rustagi A , et al. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature. 2020;588:670-675. [PMID: ] doi:10.1038/s41586-020-3014-1

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel